Godrej Consumer Products Ltd.

BSE: GODREJCP532424ISIN INE102D01028

Fast Moving Consumer Goods
Personal Care
BSE 100

Share price

₹846.15+16.65 (+2.01%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹1,275.00
52W low: ₹777.65
Off 52W high: -33.64%
1M return: +1.06%
3M return: -21.14%
6M return: -22.70%
1Y return: -27.34%
20D avg volume: 1,61,493
50 DMA: ₹866.35
200 DMA: ₹1,026.30

Key ratios Consolidated

Market cap: ₹86,600 Cr
Current price: ₹846.15
52W high / low: ₹1,275.00 / ₹777.65
Face value: ₹1.00
P/E: 43.79
P/B: 6.86
EPS (TTM): ₹19.32
Book value / share: ₹123.31
ROE: —
ROCE: 21.40%
Operating margin: —
Net margin: —
Debt / equity: 0.33
Net debt: ₹3,159 Cr
Interest cover: 8.81
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 28.7 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	4,413	4,225	3,900	4,099	3,825	3,662	3,598	3,768	3,666	3,332	3,386	3,660
	50.54	51.88	69.42	55.89	62.85	84.52	73.66	83.10	85.99	77.11	63.84	70.08
	4,464	4,277	3,970	4,155	3,888	3,746	3,672	3,852	3,752	3,409	3,449	3,730
	3,758	3,585	3,225	3,364	3,233	3,113	3,001	3,164	3,040	2,744	2,758	2,939
	1,654	1,728	1,435	1,397	1,524	1,480	1,443	1,469	1,527	1,290	1,304	1,436
	749.68	650.01	415.94	448.18	464.65	342.58	237.12	193.38	219.90	214.60	165.19	108.42
	332.77	319.31	325.07	328.09	269.97	309.01	262.47	296.12	310.61	279.58	323.70	276.08
	87.33	85.96	90.27	78.94	75.87	86.49	89.56	89.71	83.09	87.75	78.47	66.59
	77.84	75.15	76.13	66.41	65.64	59.35	72.55	61.89	50.10	49.46	49.91	53.88
	949.77	910.61	864.69	958.78	989.79	896.95	867.34	—	—	—	—	—
	705.37	692.11	744.42	790.98	654.67	633.24	670.77	687.44	712.44	664.33	691.18	790.33
	-8.88	-15.56	-92.95	-91.00	-29.66	-19.54	-31.36	-5.74	-5.78	-20.30	-2,376	-6.89
	696.49	676.55	651.47	699.98	625.01	613.70	639.41	681.70	706.66	644.03	-1,684	783.44
	173.57	172.03	199.70	202.07	165.67	161.25	227.51	183.39	215.35	193.34	208.74	202.38
	522.92	504.52	451.77	497.91	459.34	452.45	411.90	498.31	491.31	450.69	-1,893	581.06
	5.11	4.93	4.42	4.87	4.49	4.42	4.03	4.87	4.80	4.41	-18.51	5.68
Key metrics
	861.66	837.66	817.87	845.33	766.52	759.54	801.52	833.30	839.85	781.24	-1,556	903.91
	19.50%	19.80%	21.00%	20.60%	20.00%	20.70%	22.30%	22.10%	22.90%	23.40%	-46.00%	24.70%
	11.80%	11.90%	11.60%	12.10%	12.00%	12.40%	11.40%	13.20%	13.40%	13.50%	-55.90%	15.90%
	5.70%	—	5.40%	—	5.40%	—	5.70%	—	—	—	—	—
	15.40%	15.40%	8.40%	8.80%	4.30%	9.90%	6.30%	3.00%	—	—	—	—
	13.80%	11.50%	9.70%	-0.10%	-6.50%	0.40%	121.80%	-14.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	16,638	15,178	14,364	14,096	13,316	12,276	11,029	9,911	10,314	9,937
	227.73	266.17	316.12	268.95	168.41	89.71	67.07	112.30	108.76	107.55
	16,866	15,444	14,680	14,365	13,484	12,366	11,096	10,023	10,423	10,045
	13,933	12,621	11,945	11,690	11,298	10,201	8,971	8,182	8,591	8,186
	6,213	5,835	5,729	5,678	6,185	5,783	4,607	4,122	4,062	3,646
	2,264	1,671	865.00	655.54	305.18	353.65	365.01	313.08	337.36	572.13
	1,305	1,232	1,149	1,249	1,111	1,104	1,123	1,019	1,091	1,057
	342.50	331.57	350.11	296.37	175.74	110.16	126.63	217.41	224.25	160.74
	295.53	267.53	234.00	240.96	236.29	209.93	203.85	197.28	169.98	—
	3,684	3,395	3,676	—	—	—	—	1,748	1,698	1,605
	2,933	2,823	2,735	2,675	2,187	2,165	2,125	1,841	1,832	1,858
	-208.39	-233.15	-63.18	-2,477	-54.11	-9.75	-44.47	-81.05	252.56	179.56
	2,724	2,590	2,672	198.23	2,133	2,155	2,080	1,760	2,085	2,038
	747.37	728.69	819.59	758.78	430.27	371.87	359.54	263.82	256.20	404.70
	1,977	1,861	1,852	-560.55	1,702	1,783	1,721	1,497	2,342	1,634
	19.33	18.19	18.11	-5.48	16.65	17.44	16.83	14.64	22.91	—
Key metrics
	3,363	3,189	3,256	735.56	2,545	2,475	2,411	2,174	2,479	2,199
	20.21%	21.00%	22.70%	5.20%	19.10%	20.20%	21.90%	21.90%	24.00%	22.10%
	11.88%	12.30%	12.90%	-4.00%	12.80%	14.50%	15.60%	15.10%	22.70%	16.40%
	—	21.40%	23.70%	—	—	—	—	—	—	—
	12.02%	5.70%	1.90%	5.90%	8.50%	11.30%	11.30%	-3.90%	3.80%	—
	8.51%	0.50%	430.40%	-132.90%	-4.50%	3.60%	15.00%	-36.10%	43.30%	—
	—	1,919	1,977	—	—	—	—	—	—	—
	—	1.34	1.39	—	—	—	—	—	—	—
	—	0.33	0.32	—	—	—	—	—	—	—
	—	3,159	3,428	—	—	—	—	—	—	—
	—	28.7	27.8	—	—	—	—	—	—	—
Balance sheet
	—	21,334	19,672	—	—	—	—	—	—	—
	—	7,020	7,327	—	—	—	—	—	—	—
	—	976.87	454.92	—	—	—	—	—	—	—
	—	1,837	1,819	—	—	—	—	—	—	—
	—	1,659	1,419	—	—	—	—	—	—	—
	—	588.97	439.99	—	—	—	—	—	—	—
	—	2,265	1,443	—	—	—	—	—	—	—
	—	2,302	2,142	—	—	—	—	—	—	—
	—	7,707	6,934	—	—	—	—	—	—	—
	—	4,136	3,883	—	—	—	—	—	—	—
	—	4,136	3,883	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—
	—	12,653	12,004	—	—	—	—	—	—	—
Cash flow
	—	2,488	2,577	—	—	—	—	—	—	—
	—	355.39	-343.55	—	—	—	—	—	—	—
	—	-2,388	-2,182	—	—	—	—	—	—	—
	—	569.52	599.34	—	—	—	—	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	2,653	2,557	2,360	2,510	2,390	2,330	2,185	2,262	2,301	2,163	2,034	2,204
	23.97	29.40	58.34	31.38	46.70	65.32	58.94	62.88	75.38	63.79	60.57	55.34
	2,677	2,586	2,418	2,542	2,437	2,395	2,244	2,325	2,376	2,227	2,094	2,259
	2,191	2,099	1,871	1,972	1,956	1,916	1,795	1,835	1,814	1,698	1,552	1,619
	882.13	1,038	800.49	817.23	936.62	937.37	797.70	745.54	855.92	776.63	722.56	737.75
	615.84	432.32	285.92	268.52	312.00	257.33	211.33	220.20	202.48	165.80	158.83	120.32
	138.40	134.66	145.24	148.81	122.08	124.71	102.90	115.45	132.64	122.89	120.05	117.07
	56.42	55.41	53.51	47.24	45.35	53.03	54.91	48.77	44.95	42.51	37.07	36.16
	44.29	43.90	45.57	39.33	39.69	35.53	49.12	37.25	27.34	27.30	22.08	27.02
	522.44	529.67	500.34	570.39	591.10	568.09	537.35	—	—	—	—	—
	485.71	487.33	547.21	569.84	481.28	479.10	449.08	489.38	561.61	528.24	542.62	639.97
	-26.26	-3.06	7.60	-62.98	0.00	0.00	-10.16	-0.04	-0.06	-2.03	-1,068	-5.86
	459.45	484.27	554.81	506.86	481.28	479.10	438.92	489.34	561.55	526.21	-525.37	634.11
	122.12	121.55	133.20	123.80	125.03	124.41	190.43	147.80	169.01	158.37	175.55	161.53
	337.33	362.72	421.61	383.06	356.25	354.69	248.49	341.54	392.54	367.84	-700.92	472.58
	3.30	3.54	4.12	3.74	3.48	3.47	2.43	3.34	3.84	3.60	-6.85	4.62
Key metrics
	560.16	583.58	653.89	593.43	566.32	567.66	542.95	575.36	633.84	596.02	-466.22	697.29
	21.10%	22.80%	27.70%	23.60%	23.70%	24.40%	24.90%	25.40%	27.60%	27.60%	-22.90%	31.60%
	12.70%	14.20%	17.90%	15.30%	14.90%	15.20%	11.40%	15.10%	17.10%	17.00%	-34.50%	21.40%
	6.20%	—	7.10%	—	6.00%	—	5.50%	—	—	—	—	—
	11.00%	9.70%	8.00%	11.00%	3.90%	7.70%	7.40%	2.60%	—	—	—	—
	-5.30%	2.30%	69.70%	12.20%	-9.20%	-3.60%	135.50%	-27.70%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	10,080	9,474	8,910	8,411	7,667	6,952	6,254	5,474	5,679	5,355
	143.09	200.28	260.35	455.96	139.48	69.18	64.74	91.26	94.45	73.90
	10,223	9,675	9,170	8,867	7,807	7,021	6,319	5,566	5,774	5,429
	8,133	7,597	7,142	6,430	5,909	5,316	4,710	4,166	4,301	4,140
	3,537	3,492	3,176	2,965	3,366	3,064	2,394	2,043	2,031	1,885
	1,603	1,124	799.81	655.67	295.78	325.54	356.31	280.19	254.70	247.41
	567.11	540.84	473.88	498.56	372.19	347.52	417.09	319.22	351.50	355.51
	212.58	199.13	191.14	134.10	3.07	7.87	24.81	57.97	64.86	51.88
	173.09	160.12	141.01	126.88	107.99	85.61	83.38	81.37	69.07	63.31
	2,123	2,112	2,306	—	—	—	—	897.14	851.24	782.45
	2,090	2,077	2,028	2,438	1,897	1,704	1,609	1,400	1,473	1,289
	-84.70	-55.38	-12.29	-1,153	-27.59	58.21	-15.38	—	—	—
	2,005	2,022	2,016	1,285	1,870	1,762	1,594	1,400	1,473	1,289
	500.67	506.44	665.61	637.81	355.90	283.30	369.58	219.74	281.90	289.14
	1,505	1,516	1,351	647.02	1,514	1,479	1,224	1,180	1,755	999.87
	14.70	14.81	13.20	6.33	14.80	14.47	11.97	11.54	17.17	14.68
Key metrics
	2,391	2,381	2,348	1,546	1,981	1,856	1,702	1,539	1,607	1,404
	23.72%	25.10%	26.40%	18.40%	25.80%	26.70%	27.20%	28.10%	28.30%	26.20%
	14.93%	16.00%	15.20%	7.70%	19.70%	21.30%	19.60%	21.60%	30.90%	18.70%
	—	25.90%	24.70%	—	—	—	—	—	—	—
	9.97%	6.30%	5.90%	9.70%	10.30%	11.10%	14.20%	-3.60%	6.10%	—
	15.66%	12.20%	108.70%	-57.30%	2.30%	20.80%	3.80%	-32.80%	75.50%	—
	—	1,349	1,628	—	—	—	—	—	—	—
	—	1.18	1.57	—	—	—	—	—	—	—
	—	0.36	0.31	—	—	—	—	—	—	—
	—	2,737	2,454	—	—	—	—	—	—	—
	—	0.1	-1.0	—	—	—	—	—	—	—
Balance sheet
	—	13,365	13,362	—	—	—	—	—	—	—
	—	2,962	4,293	—	—	—	—	—	—	—
	—	63.24	124.50	—	—	—	—	—	—	—
	—	577.75	595.62	—	—	—	—	—	—	—
	—	676.66	697.14	—	—	—	—	—	—	—
	—	300.51	253.24	—	—	—	—	—	—	—
	—	1,422	752.12	—	—	—	—	—	—	—
	—	1,253	1,318	—	—	—	—	—	—	—
	—	4,785	4,438	—	—	—	—	—	—	—
	—	2,800	2,578	—	—	—	—	—	—	—
	—	2,800	2,578	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—
	—	7,845	8,366	—	—	—	—	—	—	—
Cash flow
	—	1,791	2,114	—	—	—	—	—	—	—
	—	200.16	75.67	—	—	—	—	—	—	—
	—	-2,052	-2,165	—	—	—	—	—	—	—
	—	441.88	486.32	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +7.31%
Sales CAGR 5Y: +8.66%
Profit CAGR 3Y: +0.04%
Profit CAGR 5Y: +4.36%
Sales YoY (TTM): +9.97%
Profit YoY (TTM): +15.66%

Consolidated

Sales CAGR 3Y: +4.46%
Sales CAGR 5Y: +6.60%
Profit CAGR 3Y: +3.02%
Profit CAGR 5Y: +1.58%
Sales YoY (TTM): +12.02%
Profit YoY (TTM): +8.51%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Coverage

INFORMED coverage

Godrej Consumer Products opens Rs 250 crore Kendal unit to add about 15 percent capacity in Indonesia

Shareholding as of 30 Sep 2026

Promoter holding: 53.07%

Quarter	September 2026	June 2026
Promoter %	53.07%	53.08%

Holder	Type	Holding	Previous	Change
Godrej Seeds & Genetics Limited	Promoter Group	27.21%	27.71%	-0.50%
Godrej Industries Limited	Promoter Group	23.23%	23.73%	-0.50%
Godrej & Boyce Manufacturing Co Ltd	Public	7.33%	7.33%	0.00%
NPS Trust through various schemes	Public	3.46%	3.46%	0.00%
Life Insurance Corporation of India through various schemes	Public	3.41%	3.00%	+0.41%
HDFC Mutual Fund through various schemes	Public	2.80%	2.40%	+0.40%
ICICI Prudential Mutual Fund through various schemes	Public	2.60%	1.95%	+0.65%
Mirae Asset Mutual Fund through various schemes	Public	1.42%	—	—
Aditya Birla Mutual Fund through various schemes	Public	1.41%	—	—
Nippon Mutual Fund through various schemes	Public	1.10%	—	—
Nadir Barjorji Godrej	Promoter	0.52%	0.02%	+0.50%
NISABA GODREJ AND PIROJSHA GODREJ (TRUSTEES OF NG FAMILY TRUST)	Promoter Group	0.28%	0.28%	0.00%
TANYA DUBASH AND PIROJSHA GODREJ (TRUSTEES OF TAD FAMILY TRUST)	Promoter Group	0.28%	0.28%	0.00%
PIROJSHA GODREJ AND NISABA GODREJ (TRUSTEES OF PG FAMILY TRUST)	Promoter Group	0.26%	0.26%	0.00%
Pirojsha Adi Godrej	Promoter Group	0.22%	0.06%	+0.16%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Godrej Consumer Products Ltd.	86,600	846.15	43.79	21.40%	+12.02% TTM	+8.51% TTM	-27.34%
Dabur India Ltd.	69,912	394.10	34.95	21.00%	+8.94% TTM	+12.28% TTM	-23.77%
Cupid Limited S	45,275	336.70	330.10	30.90%	+121.68% TTM	+188.13% TTM	+597.53%
Colgate-Palmolive (India) Ltd. S	45,086	1,657.65	33.11	107.40%	+8.72% TTM	+2.71% TTM	-24.32%
Gillette India Ltd. S	24,544	7,532.40	36.74	84.60%	+7.96% TTM	+18.59% TTM	-13.46%
Procter & Gamble Hygiene & Health Care Ltd. S	22,574	6,954.30	28.55	135.40%	-1.54% TTM	-4.58% TTM	-48.14%
Emami Ltd	16,757	381.65	22.21	28.70%	+2.82% TTM	-8.14% TTM	-29.00%
Honasa Consumer Limited	15,043	461.40	60.34	17.80%	+21.08% TTM	+238.02% TTM	+64.00%
BAJAJ CONSUMER CARE LIMITED	5,290	403.40	21.00	30.20%	+28.55% TTM	+83.77% TTM	+38.39%
RECODE STUDIOS LIMITED S	404	380.00	—	73.10%	—	—	—
Radix Industries (India) Limited S	214	142.50	68.18	18.60%	-15.00% TTM	+4.65% TTM	-24.58%
H. R. HYGIENE PRODUCTS LIMITED	135	59.51	—	—	—	—	—
THRIVE FUTURE HABITATS LIMITED	92	81.48	-54.93	-1.80%	-30.05% TTM	+52.68% TTM	-3.35%
JHS Svendgaard Laboratories Ltd. S	69	7.95	-61.15	-0.80%	+15.63% TTM	+85.12% TTM	-35.05%
Ravelcare Limited S	60	87.67	—	18.90%	—	—	—
Novateor Research Laboratories Limited S	26	43.00	238.89	1.70%	—	—	+65.38%
Paramount Cosmetics (India) Ltd S	17	36.01	78.28	8.70%	-5.95% TTM	+540.00% TTM	-7.67%
NATURO INDIABULL LIMITED S	4	2.36	-2.25	-2.00%	—	—	-32.95%

Filings & corporate actions

Recent announcements

The attached file is self explanatory4 Nov 2026 · Company Update / Earnings Call Transcript
The attached file is self explanatory29 Oct 2026 · Company Update / General
The attached file is self explanatory29 Oct 2026 · Company Update / Analyst / Investor Meet
The attached file is self explanatory29 Oct 2026 · Company Update / Investor Presentation
The attached file is self explanatory29 Oct 2026 · Company Update / Press Release / Media Release
The attached file is self explanatory29 Oct 2026 · Corp Action / Dividend Updates
The attached file is self explanatory29 Oct 2026 · Corp. Action / Dividend
The attached file is self explanatory29 Oct 2026 · Board Meeting / Outcome of Board Meeting
The attached file is self explanatory29 Oct 2026 · Result / Financial Results
The attached file is self explanatory23 Oct 2026 · Company Update / General
The attached file is self explanatory23 Oct 2026 · Company Update / Newspaper Publication
The attached file is self explanatory12 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The attached file is self explanatory7 Oct 2026 · AGM/EGM / Postal Ballot
The attached file is self explanatory.7 Oct 2026 · AGM/EGM / Postal Ballot
The attached file is self explanatory7 Oct 2026 · Company Update / Analyst / Investor Meet
Godrej Consumer Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve 1) to take on record ....6 Oct 2026 · Board Meeting / Board Meeting
The attached file is self explanatory6 Oct 2026 · Company Update / Press Release / Media Release
The attached file is self explanatory5 Oct 2026 · Company Update / General
The attached file is self explanatory2 Oct 2026 · Company Update / Allotment of ESOP / ESPS
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Godrej Seeds & Genetics Ltd26 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Godrej Industries Ltd26 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nadir Godrej & Others26 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nadir Godrej & Others26 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The attached file is self explanatory24 Sep 2026 · Company Update / General
The attached file is self explanatory24 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
The attached file is self explanatory17 Sep 2026 · Company Update / Newspaper Publication
The file attached is self explanatory.8 Sep 2026 · Company Update / Newspaper Publication
The attached file is self explanatory7 Sep 2026 · Company Update / Analyst / Investor Meet
The attached file is self-explanatory7 Sep 2026 · AGM/EGM / Postal Ballot
The attached file is self explanatory2 Sep 2026 · Company Update / Analyst / Investor Meet
The attached file is self explanatory2 Sep 2026 · Company Update / Investor Presentation
The attached file is self explanatory.28 Aug 2026 · Company Update / Newspaper Publication
The attached file is self explanatory27 Aug 2026 · Company Update / Analyst / Investor Meet
The attached file is self explanatory26 Aug 2026 · Company Update / Press Release / Media Release
The file attached is self explanatory.25 Aug 2026 · Company Update / Newspaper Publication
The attached filed is self explanatory22 Aug 2026 · Company Update / General
The attached file is self explanatory21 Aug 2026 · Company Update / Analyst / Investor Meet
The attached file is self explanatory14 Aug 2026 · Company Update / Analyst / Investor Meet
The attached file is self explanatory14 Aug 2026 · Company Update / Analyst / Investor Meet
The attached file is self explanatory14 Aug 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Interim Dividend	4 Nov 2026	4 Nov 2026	—
Interim Dividend - Rs. - 5.0000	4 Nov 2026	4 Nov 2026	—
Interim Dividend - Rs. - 5.0000	13 Aug 2026	13 Aug 2026	—
Interim Dividend - Rs. - 5.0000	12 May 2026	12 May 2026	—
Interim Dividend - Rs. - 5.0000	30 Jan 2026	30 Jan 2026	—
Interim Dividend - Rs. - 5.0000	7 Nov 2025	7 Nov 2025	—
Interim Dividend - Rs. - 5.0000	13 Aug 2025	13 Aug 2025	—
Interim Dividend - Rs. - 5.0000	13 May 2025	13 May 2025	—
Interim Dividend - Rs. - 5.0000	3 Feb 2025	3 Feb 2025	—
Interim Dividend - Rs. - 5.0000	31 Oct 2024	1 Nov 2024	—
Interim Dividend - Rs. - 5.0000	16 Aug 2024	16 Aug 2024	—

Board meetings

29 Oct 2026 Board Meeting - Financial Results
7 Aug 2026 Board Meeting - Financial Results

Godrej Consumer Products opens Rs 250 crore Kendal unit to add about 15 percent capacity in Indonesia

INFORMED Newsroom · 2026-10-12

Godrej Consumer Products, the maker of everyday mosquito repellents, soaps and hair colour used by 140.00 crore consumers globally , on 6 October 2026 inaugurated the first phase of its new Kendal factory in Indonesia as part of an IDR 50,000 crore, about Rs 250 crore, investment , adding about 15 percent home and personal care capacity at a time when its Indonesia business has turned from flat sales to double-digit growth, giving it headroom to sell more locally and export in the region .

What Kendal is

Godrej Consumer Products Indonesia, operating as a subsidiary of India-based Godrej Consumer Products Limited, inaugurated the first phase in the Kendal Special Economic Zone . The first phase has been developed across 2.5 hectares of a 5.5 hectare site and is dedicated to Household Insecticides, to serve the Indonesian market and support exports .

The investment builds on presence in Indonesia since 2010 . Since then, the business has grown 4.5 times while brands including HIT, Stella, Mitu and NYU reach approximately 1 in 4 Indonesian households . The company ranks as the second largest player in Household Insecticides in Indonesia and the number one player in Air Fresheners and Wet Tissues in Indonesia .

Managing Director and CEO Aasif Malbari said the IDR 50,000 crore investment will expand home and personal care categories capacity by approximately 15 percent . He said the expansion addresses current capacity utilization of 75-80 percent, positioning the company to meet rising regional demand and scale . He added that Kendal will become a platform for exports around the region .

The plant was built in just over a year with technology and data embedded into operations from the start, giving better visibility and faster decisions . Business Head for Indonesia Rajesh Sethuraman said it brings the company closer to real demand and gives capability to turn consumer insight into relevant innovation at scale . On people and operations, the company said inclusion is being designed into the workplace, with an ambition for women to represent 50 percent of the workforce alongside opportunities for persons with disabilities . The inauguration brought together the Ambassador of India to Indonesia, the Deputy Governor of Central Java and the Regent of Kendal alongside company leaders .

Why Indonesia needs capacity now

Kendal lands just as Indonesia has come back to stable growth after a long pricing-led slump . The company had flagged for Q2 FY27, the quarter ended 30 September 2026, that Indonesia was still recovering and was expected to grow high-teens in sales and high-single-digit in volume on better selling, share gains and healthy category trends . At whole-company level for Q2 FY27 it expected high-teens revenue growth, high-single-digit underlying volume growth and double-digit EBITDA growth . A board meeting was set for 29 October 2026 to approve detailed Q2 results .

The quarterly path shows the turn:

Sources: Q1 FY25 — ; Q2 FY25 — ; Q3 FY25 — ; Q4 FY25 — ; Q1 FY26 — ; Q2 FY26 — ; Q3 FY26 — ; Q4 FY26 — ; Q1 FY27 — .

Quarter	Indonesia net sales in Rs crore
Q1 FY25	442
Q2 FY25	479
Q3 FY25	469
Q4 FY25	476
Q1 FY26	422
Q2 FY26	447
Q3 FY26	460
Q4 FY26	492
Q1 FY27	487

On the updated presentation basis, year-on-year growth was minus 5 percent in Q1 FY26, minus 7 percent in Q2 FY26, minus 2 percent in Q3 FY26 and 3 percent in Q4 FY26 . In Q1 FY27, Indonesia sales were Rs 487 crore, up 15 percent year-on-year and 11 percent in constant currency terms . Underlying volume growth was 10 percent in Q1 FY27, led by Shampoo HC and Household Insecticides . In Q4 FY26 the business had delivered 4 percent underlying volume growth and 3 percent sales growth . In Q3 FY26 it had delivered 5 percent volume growth with revenue flattish after adjusting for a distribution change . In Q2 FY26 it had delivered 2 percent volume growth with revenue down 7 percent .

Profitability has held while volumes recovered. Indonesia operating EBITDA margin, after adjusting business support charges, royalty and technical fees, was 21.5 percent in Q1 FY27 with EBITDA growth of 11 percent year-on-year . In Q4 FY26 the margin was 28.2 percent with EBITDA growth of 1 percent year-on-year, helped by Lebaran season demand . Management has described Indonesia margins as steady .

Management links the recovery to four factors in Q1 FY27: macro, base, El Nino and faster growth in the Stella air business after stepping up media behind a global air model . It said the air business growth rate has stepped up, which it sees as sustainable . For household insecticides, it expects a strong positive in Indonesia from El Nino because Indonesia gets hotter and rains more . It said some El Nino benefit was already visible in Q1 FY27 with more expected in Q2 FY27 . The Stella LV relaunch has witnessed robust consumer traction and sell-outs .

How the spend sits on the balance sheet

The Rs 250 crore Kendal commitment sits against a consolidated scale where revenue from operations was Rs 15177.9 crore for FY26 versus Rs 14364.29 crore for FY25 . EBITDA was Rs 3189.26 crore for FY26 versus Rs 3256.0 crore for FY25, with EBITDA margin at 21.0 percent for FY26 versus 22.7 percent for FY25 . Net profit was Rs 1861.47 crore for FY26 versus Rs 1852.3 crore for FY25 .

Capex was Rs 569.52 crore for FY26 and Rs 599.34 crore for FY25 . Cash and equivalents was Rs 976.87 crore for FY26 versus Rs 454.92 crore for FY25 . Total borrowings was Rs 4135.98 crore for FY26 versus Rs 3882.59 crore for FY25, all short-term debt with long-term debt at Rs 0.0 crore . Debt to equity was 0.33 times for FY26 versus 0.32 times for FY25 . Net debt was Rs 3159.11 crore for FY26 versus Rs 3427.67 crore for FY25 . Operating cash flow was Rs 2488.46 crore for FY26 versus Rs 2576.75 crore for FY25 . Free cash flow was Rs 1918.94 crore for FY26 versus Rs 1977.41 crore for FY25 . Property, plant and equipment was Rs 2265.35 crore for FY26 versus Rs 1443.14 crore for FY25 .

In other words, recent capex has run well above depreciation while operating cash has covered it, with no long-term debt on the books . Management has only flagged qualitatively that cash may get a little squeezed amid commodity volatility in FY27 .

---